Skip to content

Addiction: all studies

Page 617 of 857: studies 6,161 to 6,170 of 8,563, newest first. Back to the addiction overview

Research

On the Plausibility of Idealism: Refuting Criticisms

Disputatio May 1, 2017 Bernardo Kastrup 35 citations

Abstract Several alternatives vie today for recognition as the most plausible ontology, from physicalism to panpsychism. By and large, these ontologies entail that physical structures circumscribe consciousness by bearing phenomenal properties within their physical boundaries. The ontology of idealism, on the other hand, entails that all physical structures are circumscribed by consciousness in...

The involvement of brain-derived neurotrophic factor in 3,4-methylenedioxymethamphetamine-induced place preference and behavioral sensitization.

Behavioural Brain Research May 1, 2017 Akihiro Mouri, Yukihiro Noda, Minae Niwa et al.

3,4-Methylenedioxymethamphetamine (MDMA) is known to induce dependence and psychosis in humans. Brain-derived neurotrophic factor (BDNF) is involved in the synaptic plasticity and neurotrophy in midbrain dopaminergic neurons. This study aimed to investigate the role of BDNF in MDMA-induced dependence and psychosis. A single dose of MDMA (10mg/kg) induced BDNF mRNA expression in the prefrontal...

MDMA-induced neurotoxicity of serotonin neurons involves autophagy and rilmenidine is protective against its pathobiology.

Neurochemistry International May 2017 Linda D Mercer, Gavin C Higgins, Chew L Lau et al.

Toxicity of 3,4-methylenedioxymethamphetamine (MDMA) towards biogenic amine neurons is well documented and in primate brain predominantly affects serotonin (5-HT) neurons. MDMA induces damage of 5-HT axons and nerve fibres and intracytoplasmic inclusions. Whilst its pathobiology involves mitochondrially-mediated oxidative stress, we hypothesised MDMA possessed the capacity to activate...

DOI: 10.1016/j.neuint.2017.01.010 (opens in new tab) Full text (opens in new tab) MDMA Neuroprotection Programmed cell death Rilmenidine +2

Novel psychoactive substances (NPS) use in severe mental illness (SMI) patients: Potential changes in the phenomenology of psychiatric diseases

Human Psychopharmacology: Clinical and Experimental May 1, 2017 Giuseppe Bersani, Elisabeth Prevete 15 citations

OBJECTIVE: Literature is quite poor about the clinical effects of novel psychoactive substances (NPS) and the long-term consequences of NPS use in psychiatric patients. Consequently, it is of the greatest interest to examine which effects NPS can exert in patients with previous severe mental illness (SMI), such as psychotic patients. The aim of this work was a comprehensive review about NPS use...

DOI: 10.1002/hup.2591 (opens in new tab) Mental illness Phenomenology philosophy Mental health

The effects and toxicity of cathinones from the users' perspectives: A qualitative study.

Human Psychopharmacology: Clinical and Experimental May 1, 2017 Sulaf Assi, Nargilya Gulyamova, Paul Kneller et al. 35 citations

The objective of this study is to explore the users' perspectives regarding the effects and toxicity of cathinones. A systematic search of Internet discussion forums yielded 303 threads relevant to the research objectives. The threads were analysed by conventional content analysis where concepts were developed from codes and themes. The study identified 3 main themes in relation to cathinone...

DOI: 10.1002/hup.2610 (opens in new tab) Full text (opens in new tab) Cathinones Content analysis Effects Novel psychoactive substances +2

A unique natural selective kappa-opioid receptor agonist, salvinorin A, and its roles in human therapeutics.

Phytochemistry May 1, 2017 André R. Cruz, Sara Domingos, Eugenia Gallardo et al. 44 citations

Until the mid-60s, only the Mazatecs, an indigenous group from Oaxaca, Mexico, used Salvia Divinorum (S. divinorum) due to its hallucinogen properties. Later it was found that the hallucinogen effects of this plant were caused by the presence of a neoclerodane diterpene Salvinorin A (salvinorin A), which is a highly selective agonist of kappa-opioid receptor (KOR) that cause more intense...

Does Cannabis Composition Matter? Differential Effects of Delta-9-tetrahydrocannabinol and Cannabidiol on Human Cognition

Current Addiction Reports April 29, 2017 Marco Colizzi, Sagnik Bhattacharyya

Purpose of ReviewThe lack of clarity about the effect of cannabis use on cognition may be attributable to the considerable heterogeneity among studies in terms of cannabis composition. This article selectively reviews studies examining the distinctive effects of cannabinoids on human cognition, particularly those of delta-9-tetrahydrocannabinol (Δ9-THC) and cannabidiol (CBD).Recent...

ПСИХОТИЧЕСКИЕ РАССТРОЙСТВА У ЛИЦ, УПОТРЕБЛЯЮЩИХ СИНТЕТИЧЕСКИЕ КАННАБИНОИДЫ (СПАЙСЫ)

April 28, 2017 Иванова Людмила Александровна, Терских Татьяна Владимировна, Тарасенко Татьяна Владимировна et al.

The study involved the group of patients (n = 40) with psychotic disorders who used synthetic cannabinoids (spice). Among the psychotic disorders according to ICD-10 we allocated intoxication delirium (F12.03; 35 %), schizophreniform disorder (F12.50; 60 %), disorder with predominantly manic psychotic symptoms (F12.55; 5 %). The average age of patients was 25.2 ± 4.4 years. Hereditary...

A Buddhist Philosophy of Global Mind for Peaceful Future

Philosophy Study April 28, 2017 Juichiro Tanabe 2 citations

While addressing global problems including conflict and violence is a common human agenda, they are human-caused: They are created and sustained through our thoughts. Though external causes and conditions cannot be ignored, the most fundamental problem is an epistemological one—our way of knowing and viewing the world. As the shape of the global conditions relies on our thoughts or ways of...

The Therapeutic Potential of Psychedelic Drugs: Past, Present, and Future.

Neuropsychopharmacology April 26, 2017 Robin Carhart-Harris, Guy M. Goodwin 680 citations

Plant-based psychedelics, such as psilocybin, have an ancient history of medicinal use. After the first English language report on LSD in 1950, psychedelics enjoyed a short-lived relationship with psychology and psychiatry. Used most notably as aids to psychotherapy for the treatment of mood disorders and alcohol dependence, drugs such as LSD showed initial therapeutic promise before...